Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines

Por Morse, Michael A., Hobeika, Amy C., Osada, Takuya, Serra, Delila, Niedzwiecki, Donna, Lyerly, H. Kim, Clay, Timothy M.
Publicado em 2008

Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease

Por Sun, Baodong, Kulis, Michael D, Young, Sarah P, Hobeika, Amy C, Li, Songtao, Bird, Andrew, Zhang, Haoyue, Li, Yifan, Clay, Timothy M, Burks, Wesley, Kishnani, Priya S, Koeberl, Dwight D
Publicado em 2009

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer

Por Morse, Michael A., Hobeika, Amy C., Osada, Takuya, Berglund, Peter, Hubby, Bolyn, Negri, Sarah, Niedzwiecki, Donna, Devi, Gayathri R., Burnett, Bruce K., Clay, Timothy M., Smith, Jonathan, Lyerly, H. Kim
Publicado em 2010

Phase I clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion

Por Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Clay, Timothy M, Broadwater, Gloria, Ren, Xiu-Rong, Chen, Wei, Castro, Henry, Lehmann, Frederic, Spector, Neil, Wei, Junping, Osada, Takuya, Lyerly, H Kim
Publicado em 2012

Correction: phase 1 clinical trial of HER2-specific immunotherapy with concomitant HER2 kinase inhibtion

Por Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Clay, Timothy M, Broadwater, Gloria, Ren, Xiu-Rong, Chen, Wei, Castro, Henry, Lehmann, Frederic, Spector, Neil, Wei, Junping, Osada, Takuya, Lyerly, H Kim, Morse, Michael A
Publicado em 2013

Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells

Por Ren, Xiu-Rong, Wei, Junping, Lei, Gangjun, Wang, Jiangbo, Lu, Jiuyi, Xia, Wenle, Spector, Neil, Barak, Larry S, Clay, Timothy M, Osada, Takuya, Hamilton, Erika, Blackwell, Kimberly, Hobeika, Amy C, Morse, Michael A, Lyerly, H Kim, Chen, Wei
Publicado em 2012

SYNERGISM FROM COMBINED IMMUNOLOGIC AND PHARMACOLOGIC INHIBITION OF HER2 IN VIVO

Por Morse, Michael A., Wei, Junping, Hartman, Zachary, Xia, Wenle, Ren, Xiu-Rong, Lei, Gangjun, Barry, William T., Osada, Takuya, Hobeika, Amy C., Peplinski, Sharon, Jiang, Haixiang, Devi, Gayathri R., Chen, Wei, Spector, Neil, Amalfitano, Andrea, Lyerly, H. Kim, Clay, Timothy M.
Publicado em 2010

Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients

Por Morse, Michael A., Chaudhry, Arvind, Gabitzsch, Elizabeth S., Hobeika, Amy C., Osada, Takuya, Clay, Timothy M., Amalfitano, Andrea, Burnett, Bruce K., Devi, Gayathri R., Hsu, David S., Xu, Younong, Balcaitis, Stephanie, Dua, Rajesh, Nguyen, Susan, Balint, Joseph P., Jones, Frank R., Lyerly, H. Kim
Publicado em 2013

A Randomized Phase II Study of Immunization With Dendritic Cells Modified With Poxvectors Encoding CEA and MUC1 Compared With the Same Poxvectors Plus GM-CSF for Resected Metastati...

Por Morse, Michael A., Niedzwiecki, Donna, Marshall, John L., Garrett, Christopher, Chang, David Z., Aklilu, Mebea, Crocenzi, Todd S., Cole, David J., Dessureault, Sophie, Hobeika, Amy C., Osada, Takuya, Onaitis, Mark, Clary, Bryan M., Hsu, David, Devi, Gayathri R., Bulusu, Anuradha, Annechiarico, Robert P., Chadaram, Vijaya, Clay, Timothy M., Lyerly, H. Kim
Publicado em 2013